Senores Pharmaceuticals Ltd manufactures and develops affordable and high-quality complex generics certified by global food and drugs authoritiesBusiness Overview: SPL is global research driven pharmaceutical company which develops and manufactures pharmaceutical products for the Regulated Markets of US, Canada and United Kingdom across various therapeutic areas and dosage forms, with...
Senores Pharmaceuticals has announced that its subsidiary, Apnar Pharma, successfully completed a USFDA inspection at its Vadodara facility with just one minor procedural observation and zero GMP issues. This regulatory clearance strengthens operational reliability and export growth potential for the firm.
Senores Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication with respect to the 9th Annual General Meeting of the Company.
Senores Pharmaceuticals Limited has informed the Exchange regarding Notice of 9th Annual General Meeting to be held on September 25, 2026
Senores Pharma to meet investors at Elara Capital conference on September 02 in Mumbai for physical group/1x1 meetings. Discussions will be based on public info only, with no unpublished price sensitive information intended to be shared.
Senores Pharmaceuticals Limited has informed the Exchange regarding copy of newspaper publication for pre dispatch of Annual Report for the forthcoming Annual General Meeting of the Company
